Tag: clinical trial

Our Research Communications & Engagement Officer, Arshiya, shares some of the most exciting results from the American Society of Clinical Oncology (ASCO) conference

Deputax-M failed to meet its target overall survival during an interim analysis of a phase 3 clinical trial in glioblastoma

Nivolumab, an immunotherapy drug, has been unsuccessful in improving overall survival in a phase 3 clinical trial when tested in newly diagnosed glioblastoma with unmethylated MGMT

A recent study highlights gaps in neuro-onoclogy services provided nationally

Hundreds more brain tumour patients are set to be offered access to experimental treatments over the next five years thanks to the Tessa Jowell BRAIN-MATRIX

A new, promising clinical trial, led by Dr Stephen Price, is opening in the UK to look at how using advanced imaging methods can predict where a glioblastoma tumour is likely to grow back before any treatment is given. This study is the first of its kind to better understand this question.

A new scanning technique, designed to show more rapidly whether cancer drugs have worked, is being trialed on a cancer patient at Addenbrooke’s hospital, Cambridge.

The new blood test focuses on germ cell cancers that are rare but take root in cells that develop into sperm and eggs and may lead to malignant tumours in childhood.

In a report published yesterday in Cancer Cell journal, American researchers are focusing on gene mutations found in a third of brain gliomas.

New imaging technology may allow neurosurgeons to distinguish between tumour tissue and normal brain tissue in real time

“Clinical trials are essential to giving brain tumour patients more of life’s best moments because we cannot get better treatment without them.” – Ken, who had a glioblastoma removed in 2014, is now on a clinical trial.

To mark International Clinical Trials Day on 20 May, we are supporting the Ok to Ask campaign, getting more patients enrolled in clinical trials.